s6y

Lakefront Biotherapeutics NV

Ticker
LKFT, GLPGF
CIK
1421876
Industry
Pharmaceutical Preparations
Formerly
GALAPAGOS NV

Ownership 37

  1. SC 13G/A Major Shareholders
  2. SC 13D/A Major Shareholders
  3. SC 13D Major Shareholders
  4. SC 13D/A Major Shareholders
  5. SC 13G/A Major Shareholders
  6. SC 13G/A Major Shareholders
  7. SC 13G Major Shareholders
  8. SC 13G/A Major Shareholders
  9. SC 13G Major Shareholders
  10. SC 13G Major Shareholders

All 37 ownership filings

Prospectus 24

  1. 424B3 Prospectus filed pursuant to Rule 424(b)(3)
  2. S-8 Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
  3. S-8 Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
  4. S-8 Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
  5. S-8 Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
  6. S-8 Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
  7. S-8 Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
  8. S-8 Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
  9. 424B3 Prospectus filed pursuant to Rule 424(b)(3)
  10. 424B5 Prospectus filed pursuant to Rule 424(b)(5)

All 24 prospectus filings

Other 488

  1. 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
  2. 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
  3. 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
  4. 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
  5. 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
  6. 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
  7. 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
  8. 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
  9. 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
  10. 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

All 488 other filings